Attached files

file filename
EX-99.1 - PRESS RELEASE - ADVANCED CELL TECHNOLOGY, INC.actc_8k-ex9901.htm

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE

 

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):   May 8, 2012

 

ADVANCED CELL TECHNOLOGY, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware   000-50295   87-0656515

(State or other jurisdiction

of incorporation)

  (Commission File Number)   (IRS Employer Identification Number)
 
33 Locke Drive, Marlborough, MA 01752
(Address of principal executive offices, including zip code)
 
(508) 756-1212
(Registrant’s telephone number, including area code)
 
 
(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
   
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CAR 240.13e-4(c))

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On May 8, 2012, Advanced Cell Technology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2012. A copy of the Company’s press release announcing these financial results is attached hereto as Exhibit 99.1.

  

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No. Description
99.1 Press Release dated May 8, 2012.

 

 

2
 

 

 

SIGNATURES 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ADVANCED CELL TECHNOLOGY, INC.
   
   
  By: /s/ Gary Rabin
    Gary Rabin
    Chief Executive Officer
 Dated: May 9, 2012  

 

 

3
 

 

EXHIBIT INDEX

 

 

 

 

 

Exhibit No. Description
99.1 Press Release dated May 8, 2012.

 

 

 

 

 

 

 

 

 

4